NLTX · Categories · Form 5

NLTX - SEC Form 5 annual insider statements

Neoleukin Therapeutics Inc. (NLTX) sec form 5 annual insider statements - real-time wire coverage filtered to Form 5 only.

Recent Form 5 for NLTX

• 1577d
  SEC Form 5: Drachman Jonathan G gifted 150,000 shares and received a gift of 150,000 shares, decreasing direct ownership by 3% to 2,198,686 units

  5 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)

Other NLTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• DEF 14A
• M&A
• Earnings
• Dividends